Your Article Summary
Viral Clearance Strategy Using a Three-Tier Orthogonal Technology Platform
BioPharm, 09/16/08
emoving viral contaminants from animal cell-culture derived biologicals is a major challenge of downstream purification because it involves laborious and time-consuming techniques that result in increased manufacturing costs. Updated regulatory guidelines demanding higher safety margins and enforcing good manufacturing practices are leading to tighter specifications.
Today in Biotechnology...keeping you current
Receive free subspecialty "5-minute updates" via email
Indias Future as a Biologics Manufacturing Hub
BioPharm, 03/18/10
Abbott Announces Positive Data From ABSORB Trial on Its Bioresorbable Vascular Scaffold Technology
Abbott, 03/16/10
Bayer CropScience and Mendel Biotechnology expand collaboration in crop protection
BayNews International, 03/09/10
Article Search
Sponsor


See Latest Articles


